Edward Paul Gerstenfeld

Safebeat Rx Inc.

NIH Rank #6595
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.8M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#6,595
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.8M across 2 grants · National rank #6595.

Top grants by award amount

Edward Paul Gerstenfeld's NIH grant portfolio, ranked by award amount.

  • 1R44HL167294-01A1R44
    Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home
    $994.1K
    award amount
  • 5R01HL159069-03R01
    Elucidating Mechanistic Relationships Between Atrial Ectopy, Atrial Remodeling and Atrial Fibrillation
    $785.3K
    award amount

Affiliations

Institutions that have administered grants for Edward Paul Gerstenfeld.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Safebeat Rx Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6595
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Edward Paul Gerstenfeld.